Navigation Links
Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2019
Date:5/15/2012

Preclinical Pipeline 545.4 Neuroendocrine Carcinoma Therapeutics- Clinical Pipeline by Mechanism of Action 555.5 Technology Trends Analytic Framework 555.6 Neuroendocrine Carcinoma Therapeutics - Key Late Stage Pipeline Drugs in Clinical Development 585.7 Molecule Profile for Key Late Stage Pipeline Drugs under Clinical Development 585.7.1 Avastin (bevacizumab) 585.7.2 Lutathera ([177Lutetium]-DOTA0-Tyr3-Octreotate) 595.7.3 Paseriotide (SOM 230) 605.7.4 Somatuline Autogel (lanreotide acetate) 615.8 Key Takeaway 616 Neuroendocrine Carcinoma Therapeutics - Clinical Trials Mapping 626.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 626.2 Clinical Trials by Phase 636.3 Clinical Trials by Trial Status 646.4 Prominent Sponsors 656.5 Top Companies Participating in Neuroendocrine Carcinoma Therapeutics Clinical Trials 677 Neuroendocrine Carcinoma Therapeutics- Strategic Assessment 687.1 Future Market Competition Scenario 688 Neuroendocrine Carcinoma Therapeutics - Future Players 708.1 Introduction 708.2 Company Profiles for the Promising Drugs 708.2.1 Advanced Accelerator Applications S.A 708.2.2 Novartis AG 718.2.3 F. Hoffmann-La Roche 738.2.4 Ipsen SA 748.3 Other Companies in the Neuroendocrine Carcinoma Therapeutics Market 769 Neuroendocrine Carcinoma Therapeutics- Licensing and Partnership Deals 7710 Neuroendocrine Carcinoma Therapeutics - Appendix 7910.1 Market Definitions 7910.2 Abbreviations 7910.3 Methodology 8010.3.1 Coverage 8110.3.2 Secondary Research 8110.3.3 Forecasting 8110.3.4 Primary Research 8310.3.5 Expert Panel Validation 8410.4 Contact Us 8410.5 Disclaimer 8410.6 Bibliography 84

List of Tables

Table 1: GEP-NETs WHO Classification 7Table 2:GEP-NETs Classification 8Table 3: Historical Prevalence for Neuroendocrine Carcinoma* for Seven Major Markets 9Table 4: Forecast Prevalence for Neuroendocrine Carcinoma* for Seven Major Markets 10Table 5: Symptoms of Pancreatic NETs/Islet Cell Tumors 12Table 6:Diagnosis Techniques by S
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Positive Phase 2 Trial Results from Neuroendocrine Tumor Cohort Presented at CIRSE
2. Cylene Pharmaceuticals Initiates Phase II Clinical Trial of Quarfloxin (CX-3543) in Patients With Carcinoid/Neuroendocrine Tumors
3. Childhood Obesity Linked to Increased Risk of Hepatocellular Carcinoma in Adulthood
4. Argos Therapeutic Arcelis™ Immunotherapy AGS-003 in Combination With Sunitinib Shows Statistically Significant Correlation of Immune System Response to Overall Survival in Phase 2 Study in Patients with Advanced Renal Cell Carcinoma (RCC)
5. SFJ Pharma Ltd. II, Announces Agreement With Pfizer to Develop Axitinib for Adjuvant Treatment of Renal Cell Carcinoma
6. Targeted Gold Nanoparticles and Noninvasive Radio Fields Attacking One of the Deadliest and Least Curable Types of Cancer: Pancreatic Carcinoma
7. Aegera Therapeutics Reports Survival Data from the Phase 1 Portion of its Phase 1-2 Study of AEG35156 in Combination with Sorafenib in Patients with Advanced Hepatocellular Carcinoma
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Aratana Therapeutics Appoints Craig Tooman to Board of Directors
10. Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy
11. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... way to create a highly sensitive chemical sensor based ... have unique electronic properties that the researchers were able ... by 300 times. , The study is available online ... , Amin Salehi- Khojin, asst professor of mechanical and ... student and Bijandra Kumar, post doc where they are ...
(Date:9/22/2014)... Dallas, Texas (PRWEB) September 22, 2014 ... current state of the M-Phenylenediamine (mPDA) industry in ... of the industry, including definitions, applications and industry chain ... are provided with a focus on history, developments, trends ... the international and Chinese situation is also offered. , ...
(Date:9/22/2014)... September 22, 2014 Topical BioMedics, Inc., ... in pain end their suffering, restoring hope an quality ... This is only possible because of the innovative cellular ... cream technology a reality. , The company was ... by Lou Paradise (president, chief of research, and Topricin ...
(Date:9/22/2014)... Follow us on LinkedIn ... has groomed and nurtured anti-aging products and technologies ... on appearance maintenance is benefitting the market for ... obtained from the bacterium, Clostridium Botulinum, which arrests ... With cosmetic indications for botulinum toxin ranging from ...
Breaking Biology Technology:Graphene imperfections key to creating hypersensitive 'electronic nose' 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 2Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 3Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 4Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 5Topical BioMedics (Topricin) Celebrates 20 Years of Providing Hope and Quality of Life...As Topricin Is Declared “The 21st Century Standard of Care for Pain Management” 6Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 2Strong Demand for Non-Invasive Cosmetic Procedures Drives the Global Botulinum Toxin Market, According to New Report by Global Industry Analysts, Inc. 3
... ... PharmSource Information Services, Inc. announces the publication of a ... How to Minimize Your Risk." This incisive resource provides guidelines on ... risk for companies doing business throughout the world. "The U.S. Foreign ...
... SAN DIEGO, INDIANAPOLIS and CAMBRIDGE, Mass., July 7 ... Lilly and Company (NYSE: LLY ) and Alkermes, ... New Drug Application (NDA) for exenatide once weekly has been ... (FDA). , , Exenatide once weekly is an investigational ...
... Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: ... Sun Pharmaceutical Industries Ltd. (Sun Pharma), immediately following Sun ... Drug Administration (FDA) for its Abbreviated New Drug Application ... tablets are an androgen receptor inhibitor indicated for use ...
Cached Biology Technology:PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry 2PharmSource Releases White Paper on Role of U.S. Foreign Corrupt Practices Act (FCPA) in the Bio/Pharma Industry 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 2New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 3New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 4New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 5New Drug Application for Exenatide Once Weekly Accepted for Review by FDA 6Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets 2
(Date:9/19/2014)... the Jimmy Durante of dinosaurs a newly ... The new dinosaur, named Rhinorex condrupus ... Brigham Young University, lived in what is now ... Late Cretaceous period. , Rhinorex, which translates roughly ... close relative of other Cretaceous hadrosaurs like Parasaurolophus ...
(Date:9/19/2014)... professor will study the unique bioelectric signaling system of ... people,s health. The OU researcher is working to ... produce the signals used to map the world around ... rate of 500-600 discharges a second throughout their lives. ... are extreme, but necessary for survival. , "There is ...
(Date:9/19/2014)... did not evolve for the sake of fairness per ... continued cooperation, so say Frans de Waal, PhD, and ... inequity aversion (IA), which is defined as a negative ... Science . , Their conclusion comes after ... address their hypothesis that it is the evolution of ...
Breaking Biology News(10 mins):New hadrosaur noses into spotlight 2Evolution of responses to (un)fairness 2Evolution of responses to (un)fairness 3
... and 26, over 50 scientists gathered for a two-day ... of knowledge on the feedbacks between deforestation and climate ... avoid catastrophic change. Collaborators from the Woods Hole Research ... de Pesquisa Ambiental da Amaznia, Harvard University, Universidade Federal ...
... This release is available in Spanish . ... University of the Basque Country (UPV/EHU), providing a tool to ... monthly or even weekly basis, thus enabling studies of the ... anchovy ( Engraulis encrasicolus , Linneaus 1875) is a coastal ...
... The following statement was,issued today by the U.S. ... Good afternoon. I want to thank Interior Minister ... our visit and for their,dedication to maintaining the ... The cooperation between our two countries on matters ...
Cached Biology News:Workshop assesses interactions between climate, forests and land use in the Amazon Basin 2Workshop assesses interactions between climate, forests and land use in the Amazon Basin 3Researcher provides tool to enable determination of age of anchovies with greater precision 2Researcher provides tool to enable determination of age of anchovies with greater precision 3Remarks Prepared for Delivery By Attorney General Michael B. Mukasey At the Ministerial Press Conference 2
Anti-Rsk2/MAPKAP Kinase 1b, #0 SK2/MAPKAP K1 beta Smartpool&t 3T3 cell lysate Non-specific Control Pool , #D 1X Universal Buffer...
Request Info...
Assay Kit formatted for flow cytometric detection of levels of phosphorylated histone H2A.X....
Request Info...
Biology Products: